Interacting JNK-docking Sites in MKK7 Promote Binding and Activation of JNK Mitogen-activated Protein Kinases*

D-sites are a class of MAPK-docking sites that have been found in many MAPK regulators and substrates. A single functional, high affinity D-site has been identified near the N terminus of each of the MAPK kinases (MKKs or MEKs) MEK1, MEK2, MKK3, MKK4, and MKK6. Here we demonstrated that MKK7 recognizes its target JNK by a novel mechanism involving a partially cooperative interaction of three low affinity D-sites in the N-terminal domain of MKK7. Mutations of the conserved residues within any one of the three docking sites (D1, D2, and D3) disrupted the ability of the N-terminal domain of MKK7β to bind JNK1 by about 50–70%. Moreover, mutation of any two of the three D-sites reduced binding by about 80–90%, and mutation of all three reduced binding by 95%. Full-length MKK7 containing combined D1/D2 mutations was compromised for binding to JNK1 and exhibited reduced JNK1 kinase activity when compared with wild-type MKK7. Peptide versions of the D-sites from MKK4 or the JIP-1 scaffold protein inhibited MKK7-JNK binding, suggesting that all three JNK regulators bind to the same region of JNK. Moreover, peptide versions of any of the three D-sites of MKK7 inhibited the ability of JNK1 and JNK2 to phosphorylate their transcription factor substrates c-Jun and ATF2, suggesting that D-site-containing substrates also compete with MKK7 for docking to JNK. Finally, MKK7-derived D-site peptides exhibited selective inhibition of JNK1 versus ERK2. We conclude that MKK7 contains three JNK-docking sites that interact to selectively bind JNK and contribute to JNK signal transmission and specificity.

[1]  H. Madhani,et al.  Principles of MAP kinase signaling specificity in Saccharomyces cerevisiae. , 2004, Annual review of genetics.

[2]  Sam-Yong Park,et al.  Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125 , 2004, The EMBO journal.

[3]  T. Herdegen,et al.  Context-specific inhibition of JNKs: overcoming the dilemma of protection and damage. , 2005, Trends in pharmacological sciences.

[4]  C. Weston,et al.  The JNK signal transduction pathway. , 2007, Current opinion in genetics & development.

[5]  Lee Bardwell,et al.  A conserved protein interaction network involving the yeast MAP kinases Fus3 and Kss1 , 2004, The Journal of cell biology.

[6]  B. Cairns,et al.  Signaling in the yeast pheromone response pathway: specific and high-affinity interaction of the mitogen-activated protein (MAP) kinases Kss1 and Fus3 with the upstream MAP kinase kinase Ste7 , 1996, Molecular and cellular biology.

[7]  A. Manning,et al.  Targeting JNK for therapeutic benefit: from junk to gold? , 2003, Nature Reviews Drug Discovery.

[8]  J. Yasuda,et al.  A mammalian scaffold complex that selectively mediates MAP kinase activation. , 1998, Science.

[9]  M. Bogoyevitch,et al.  The c-Jun N-terminal protein kinase family of mitogen-activated protein kinases (JNK MAPKs). , 2001, The international journal of biochemistry & cell biology.

[10]  L. Bardwell,et al.  Mitogen-activated protein kinase (MAPK)-docking sites in MAPK kinases function as tethers that are crucial for MAPK regulation in vivo. , 2006, Cellular signalling.

[11]  H. Enslen,et al.  Molecular determinants that mediate selective activation of p38 MAP kinase isoforms , 2000, The EMBO journal.

[12]  A. Lin,et al.  Identification of c-Jun NH2-terminal Protein Kinase (JNK)-activating Kinase 2 as an Activator of JNK but Not p38* , 1997, The Journal of Biological Chemistry.

[13]  E. Wagner,et al.  MKK7 couples stress signalling to G2/M cell-cycle progression and cellular senescence , 2004, Nature Cell Biology.

[14]  M. Karin,et al.  Molecular cloning and characterization of human JNKK2, a novel Jun NH2-terminal kinase-specific kinase , 1997, Molecular and cellular biology.

[15]  Lee Bardwell,et al.  A Docking Site in MKK4 Mediates High Affinity Binding to JNK MAPKs and Competes with Similar Docking Sites in JNK Substrates* , 2003, Journal of Biological Chemistry.

[16]  Caleb J Bashor,et al.  The Ste5 Scaffold Allosterically Modulates Signaling Output of the Yeast Mating Pathway , 2006, Science.

[17]  L. Flatauer,et al.  A Conserved Docking Site in MEKs Mediates High-affinity Binding to MAP Kinases and Cooperates with a Scaffold Protein to Enhance Signal Transmission* , 2001, The Journal of Biological Chemistry.

[18]  R. Flavell,et al.  MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines. , 2001, Genes & development.

[19]  Lee Bardwell,et al.  Docking sites on mitogen-activated protein kinase (MAPK) kinases, MAPK phosphatases and the Elk-1 transcription factor compete for MAPK binding and are crucial for enzymic activity. , 2003, The Biochemical journal.

[20]  E. Nishida,et al.  Identification of a docking groove on ERK and p38 MAP kinases that regulates the specificity of docking interactions , 2001, The EMBO journal.

[21]  A. Bardwell,et al.  Anthrax lethal factor-cleavage products of MAPK (mitogen-activated protein kinase) kinases exhibit reduced binding to their cognate MAPKs. , 2004, The Biochemical journal.

[22]  H. Nishina,et al.  Activation of Stress-activated Protein Kinases/c-Jun N-terminal Protein Kinases (SAPKs/JNKs) by a Novel Mitogen-activated Protein Kinase Kinase (MKK7)* , 1997, The Journal of Biological Chemistry.

[23]  A. Lin,et al.  Role of JNK activation in apoptosis: A double-edged sword , 2005, Cell Research.

[24]  P. Cohen,et al.  Phosphorylation of microtubule‐associated protein tau by isoforms of c‐Jun N‐terminal kinase (JNK) , 2004, Journal of neurochemistry.

[25]  Lee Bardwell,et al.  Mitogen-Activated Protein Kinases with Distinct Requirements for Ste5 Scaffolding Influence Signaling Specificity in Saccharomyces cerevisiae , 2005, Molecular and Cellular Biology.

[26]  J. Wilsbacher,et al.  The N-terminal ERK-binding Site of MEK1 Is Required for Efficient Feedback Phosphorylation by ERK2 in Vitro and ERK Activation in Vivo * , 1999, The Journal of Biological Chemistry.

[27]  A. Sharrocks,et al.  Docking domains and substrate-specificity determination for MAP kinases. , 2000, Trends in biochemical sciences.

[28]  Alejandra Bruna,et al.  Glucocorticoid receptor–JNK interaction mediates inhibition of the JNK pathway by glucocorticoids , 2003, The EMBO journal.

[29]  Kunio Kondoh,et al.  The duration, magnitude and compartmentalization of ERK MAP kinase activity: mechanisms for providing signaling specificity , 2005, Journal of Cell Science.

[30]  D. Bar-Sagi,et al.  Suppression of Ras-stimulated transformation by the JNK signal transduction pathway. , 2003, Genes & development.

[31]  T. Katada,et al.  Different Properties of SEK1 and MKK7 in Dual Phosphorylation of Stress-induced Activated Protein Kinase SAPK/JNK in Embryonic Stem Cells* , 2003, The Journal of Biological Chemistry.

[32]  P. Cohen,et al.  Synergistic activation of SAPK1/JNK1 by two MAP kinase kinases in vitro , 1998, Current Biology.

[33]  E. Goldsmith,et al.  Docking motif interactions in MAP kinases revealed by hydrogen exchange mass spectrometry. , 2004, Molecular cell.

[34]  T. Mak,et al.  The Stress Kinase Mitogen-Activated Protein Kinase Kinase (Mkk)7 Is a Negative Regulator of Antigen Receptor and Growth Factor Receptor–Induced Proliferation in Hematopoietic Cells , 2001, The Journal of experimental medicine.

[35]  R. Davis,et al.  Signal Transduction by the JNK Group of MAP Kinases , 2000, Cell.

[36]  M. Karin,et al.  AP-1 as a regulator of cell life and death , 2002, Nature Cell Biology.

[37]  E. Nishida,et al.  A conserved docking motif in MAP kinases common to substrates, activators and regulators , 2000, Nature Cell Biology.

[38]  A. Sharrocks,et al.  Specificity Determinants in MAPK Signaling to Transcription Factors* , 2002, The Journal of Biological Chemistry.

[39]  R. Davis,et al.  Regulation of MAP kinases by docking domains , 2001, Biology of the cell.

[40]  J. Avruch,et al.  Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. , 2001, Physiological reviews.

[41]  Michael Karin,et al.  A central role for JNK in obesity and insulin resistance , 2002, Nature.

[42]  E. Nishida,et al.  A novel SAPK/JNK kinase, MKK7, stimulated by TNFα and cellular stresses , 1997, The EMBO journal.

[43]  Ming-tao Li,et al.  SP600125, a new JNK inhibitor, protects dopaminergic neurons in the MPTP model of Parkinson’s disease , 2004, Neuroscience Research.

[44]  A. Sharrocks,et al.  The Elk-1 ETS-Domain Transcription Factor Contains a Mitogen-Activated Protein Kinase Targeting Motif , 1998, Molecular and Cellular Biology.

[45]  H. Kaneto,et al.  Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide , 2004, Nature Medicine.

[46]  S. Noselli,et al.  MKK7 Is A Stress-activated Mitogen-activated Protein Kinase Kinase Functionally Related to hemipterous * , 1997, The Journal of Biological Chemistry.

[47]  M. Karin,et al.  Mammalian MAP kinase signalling cascades , 2001, Nature.

[48]  M. Rudnicki,et al.  Activation of JNK1 contributes to dystrophic muscle pathogenesis , 2001, Current Biology.

[49]  J. Uney,et al.  Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Radha Akella,et al.  Crystal structures of MAP kinase p38 complexed to the docking sites on its nuclear substrate MEF2A and activator MKK3b. , 2002, Molecular cell.

[51]  R. Davis,et al.  Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH2-terminal kinase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[52]  D. Morrison,et al.  Regulation of MAP kinase signaling modules by scaffold proteins in mammals. , 2003, Annual review of cell and developmental biology.

[53]  C. Tournier,et al.  The MKK7 Gene Encodes a Group of c-Jun NH2-Terminal Kinase Kinases , 1999, Molecular and Cellular Biology.

[54]  A. Whitmarsh,et al.  Docking Interactions in the c-Jun N-terminal Kinase Pathway* , 2004, Journal of Biological Chemistry.

[55]  C. Tournier,et al.  A Novel Mitogen-Activated Protein Kinase Docking Site in the N Terminus of MEK5α Organizes the Components of the Extracellular Signal-Regulated Kinase 5 Signaling Pathway , 2005, Molecular and Cellular Biology.

[56]  A. Lin Activation of the JNK signaling pathway: Breaking the brake on apoptosis , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.